Bcl-2 family proteins are essential for platelet survival-Reference-Cited by-同舟云学术

Bcl-2 family proteins are essential for platelet survival

Published:2007-01-05 Issue:5 Volume:14 Page:943-951
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Zhang H,Nimmer P M,Tahir S K,Chen J,Fryer R M,Hahn K R,Iciek L A,Morgan S J,Nasarre M C,Nelson R,Preusser L C,Reinhart G A,Smith M L,Rosenberg S H,Elmore S W,Tse C

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/4402081.pdf

Reference31 articles.

1. Troy GC . An overview of hemostasis. Vet Clin North Am Small Anim Pract 1988; 18 (1): 5–20.

2. Packham MA . Role of platelets in thrombosis and hemostasis. Can J Physiol Pharmacol 1994; 72 (3): 278–284.

3. Wolf BB, Goldstein JC, Stennicke HR, Beere H, Amarante-Mendes GP, Salvesen GS et al. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood 1999; 94 (5): 1683–1692.

4. Shcherbina A, Remold-O'Donnell E . Role of caspase in a subset of human platelet activation responses. Blood 1999; 93 (12): 4222–4231.

5. Kaluzhny Y, Ravid K . Role of apoptotic processes in platelet biogenesis. Acta Haematol 2004; 111 (1–2): 67–77.

Cited by 367 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial bioenergetics as a cell fate rheostat for responsive to Bcl-2 drugs: New cues for cancer chemotherapy;Cancer Letters;2024-07

2. Drug combinations with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids;2024-06-14

3. PROteolysis‐Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives;MedComm;2024-06

4. Thalidomide derivatives degrade BCL-2 by reprogramming the binding surface of CRBN;Cell Reports Physical Science;2024-05

5. Venetoclax-Related Neutropenia in Leukemic Patients: A Comprehensive Review of the Underlying Causes, Risk Factors, and Management;Pharmaceuticals;2024-04-10